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Background/aim: In Turkey, few systematic reviews have analyzed the results of studies on the isolation rates of urinary tract infection
agents and their antibiotic susceptibilities. This review was done to fill this gap and enable the correct application of guideline-based
medical therapy by determining the isolation rates and antibiotic susceptibilities of different Enterobacteriaceae species in Turkey.
Materials and methods: Relevant studies found from various databases with the help of previously specified search strategies were
examined and eliminated according to eligibility criteria. The remaining 22 studies were included in this systematic review.
Results: Escherichia coli was the most frequently isolated species among all agents in both in- and outpatient settings. Only the antibiotic
susceptibility data of E. coli could be analyzed because among the 22 studies only E. coli had adequate antibiotic susceptibility data to
be analyzed. The calculated resistance rates of the most frequently preferred antibiotics (trimethoprim/sulfamethoxazole, ciprofloxacin,
and ceftriaxone) were 46%, 32%, and 19% for outpatients and 54%, 48%, and 28% for inpatients, respectively.
Conclusion: The resistance profiles of commonly used antimicrobial agents are much higher than the thresholds set by international
guidelines. Hence, treatment algorithms for urinary tract infections should be designed according to Turkey’s antimicrobial resistance
patterns.
Key words: Systematic review, Enterobacteriaceae, Turkey, urinary tract infections

1. Introduction
Urinary tract infections are one of the most commonly
seen infections in both in- and outpatient settings (1,2). In
Turkey, although studies have been conducted on urinary
tract infection agents and their antibiotic susceptibilities,
they have generally been regional studies covering limited
time periods. There are a limited number of reviews to pool
the results of different studies and reveal the isolation rates
of different species and their antibiotic susceptibilities in
Turkey.
The objective of this review is to contribute to the
advancement of empirical treatment, particularly in
primary healthcare settings, and to reveal the isolation
rates of Enterobacteriaceae species, the most common
agents of urinary tract infections, and their antibiotic
susceptibilities.
2.Materials and methods
The method used in this review was established by
considering the items provided in the Preferred
* Correspondence: cyuruyen@gmail.com

Reporting Items for Systematic Review and MetaAnalysis Protocols-2015 (PRISMA-P) statement. Based
on this guide, information resources were identified and
searching strategies were established by a team consisting
of three microbiologists, one medical pharmacologist,
and one biostatistician who then reviewed the studies and
evaluated the data collected according to the specified
acceptance/rejection criteria.
2.1. Information resources to review and searching
strategies
Four team members independently searched articles
in the Google Scholar, PubMed and ULAKBİMEKUAL national databases. During the database search,
“Escherichia coli, Klebsiella, Proteus, Enterobacteriaceae,
urinary culture, Turkey”, “Escherichia coli, Klebsiella,
Proteus, Enterobacteriaceae, antibiotic resistance, Turkey”,
“Escherichia coli, Klebsiella, Proteus, Enterobacteriaceae,
antibiotic susceptibility, Turkey”, and “Escherichia coli,
Klebsiella, Proteus, Enterobacteriaceae, urinary tract
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infection, Turkey” were used as the keyword groups, and
searching was performed in both Turkish and English.
2.2. Acceptance/rejection criteria
The following acceptance and rejection criteria were
established to use in identifying the articles to assess in the
review:
· The study must have been conducted in Turkey.
· The study must have been published between 2009
and 2015.
· The language of publication must be Turkish or
English.
· The study must be a research paper published in peerreviewed journals.
· The study must have been performed on individuals
above 18 years of age.
· The article must involve at least one result of agent
frequency or antibiotic susceptibility.
· At least 30 strains must have been reviewed in the
article.
· The results of antibiotic susceptibility tests must have
been evaluated with disk diffusion or minimum inhibitory
concentration (MIC) results according to Clinical and
Laboratory Standards Institute (CLSI) or European
Committee on Antimicrobial Susceptibility Testing
(EUCAST) criteria.
Data on both lower and upper urinary systems were
included. Studies that provided the results of the frequency
of urinary tract infection agents and their antibiotic
susceptibilities mixed with the results of the agents isolated
in other system infections and their susceptibilities without
specifically indicating the former were not included in the
review. Data regarding hospital- and community-acquired
infections were separated; however, both were included.
Studies involving specific patient groups (e.g., patients
who developed neurogenic bladder due to spinal cord
injury) were not included.
2.3. Analysis of studies and evaluation of data
Articles found in the database search were collected on
a digital platform. Two microbiologists from the team
evaluated the articles in accordance with the acceptance/
rejection criteria and allocated the ones that complied with
the criteria. Data from the selected articles were collected
through Microsoft Excel Office and charts and tables were
generated. A medical microbiologist and a biostatistician
were assigned for this stage.
Articles were categorized primarily based on
whether they involved in- or outpatient groups to
analyze the frequency of isolation of agents. Afterwards,
the geographic regions where studies originated were
determined considering the Nomenclature of Territorial
Units for Statistics (NUTS) of Turkey. Tables showing
isolation rates (in %) of agents included in the selected
articles were generated. Antibiotic resistance was
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investigated for ampicillin, cefuroxime, ceftriaxone,
ciprofloxacin, gentamicin, cotrimoxazole, carbapenems,
piperacillin-tazobactam, and nitrofurantoin. Extendedspectrum beta-lactamase (ESBL) production was noted,
if indicated. Resistance rates in percentages were reported
separately for in- and outpatient settings. Standardized
resistance rates were calculated to minimize the effects
of the difference in the number of strains between the
articles. Standardized rates are a statistical measure of any
rates in a population. These are adjusted rates considering
the vital differences between populations. They are
calculated by dividing the number of strains of a species
that are resistant to an antibiotic by the number of strains
of the same species that are expected to be resistant to the
same antibiotic considering the average resistance rate in
Turkey. For example, the number of ampicillin-resistant
Escherichia coli was found to be 59 in 107 strains in an
article published from Western Anatolia. If the average of
ampicillin-resistant E. coli in Turkey is 61.5%, the number
of resistant E. coli expected for that study would be 66.
In that case, the standardized resistance rate would be
calculated as 59/66 × 100 = 89.9. This method is a tool to
observe deviations from average resistance rates. As the
standardized rate deviates more from 100, the resistance
rates of those analyzed strains become more extreme.
3. Results
The search yielded 94 articles that had been published
between 2009 and 2015. After evaluations were performed
based on the acceptance/rejection criteria, the review was
carried out on 22 articles (3–24). It was observed that
13 of these articles contained data regarding outpatients
alone, whereas four of them contained data regarding both
in- and outpatient settings. The distribution of studies by
NUTS is shown in Figure 1.
The number of articles among those selected as per
the suitability criteria that reached the specified number
of strains of at least 30 for different species was 22, 6,
and 1 for E. coli, Klebsiella and Proteus, and Enterobacter,
respectively. None of the articles reviewed reached the
number of strains of 30 for the other Enterobacteriaceae
genera. The frequencies of isolation of E. coli and Klebsiella
spp. among all agents in in- and outpatients are shown in
Figures 2 and 3. E. coli was more frequently isolated from
outpatients (70% of all agents) than inpatients (49% of all
agents). Klebsiella spp. was more commonly isolated from
inpatients (9.9%) than outpatients (7.3%).
When calculation of antibiotic resistance rates was
attempted, it was found that there was a small number of
articles reporting antibiotic resistance for other species
excluding E. coli (e.g., three articles for Klebsiella).
Therefore, antibiotic resistance was investigated for only E.
coli. The total number of strains investigated for antibiotic
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Number of studies
ENTIRE COUNTRY
MEDITERRANEAN (Adana, Antalya, Osmaniye, K.
Mara , Mersin, Hatay, Burdur, Isparta)
STANBUL ( stanbul)

Number
of Studies

MIDDLE EAST ANATOLIA (Bingöl, Bitlis, Mu ,
Tunceli, Van, Elazı , Hakkari,Malatya)
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EAST MARMARA (Bursa, Kocaeli, Sakarya,
Yalova, Bilecik, Bolu, Eski ehir, Düzce)
AEGEAN (Manisa,Aydın, zmir, Mu la,
Denizli,Afyon, Kütahya, U ak)
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Figure 1. Distribution of studies by NUTS.
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Figure 2. The frequency of isolation (%) of E. coli and Klebsiella spp. from outpatients in different studies.

resistance in 10,090 outpatients and 6065 inpatients is
shown in Table 1.
Antibiotic resistance rates for E. coli across Turkey were
calculated individually for in- and outpatients. Resistance
rates are shown in Figures 4 and 5.
Standardized resistance rates were calculated from
the expected and observed resistance rates. Standardized
resistance rates were found to remain in the range of
70–130 for ampicillin, cephalosporins, ciprofloxacin,
and cotrimoxazole, which were included in most of
the publications from various geographic regions. This
indicated that resistance demonstrated a homogeneous
distribution for the relevant antibiotics between different
regions. Among the publications, it was seen that there
was a limited number of publications studying resistance

against other antibiotics and that standardized resistance
rates established for these antibiotics were distributed in
a wider range. For example, carbapenem resistance was
studied in only four of nine articles investigating the
resistance rates for inpatients and standardized resistance
rates established for carbapenem ranged between 26
and 471. Standardized resistance rates for cotrimoxazole
obtained from 14 articles analyzing outpatients are given
as an example in Table 2.
4. Discussion
Findings obtained from 22 publications selected among
94 based on the suitability criteria specified during the
preparation of the review are provided above. During
the analysis of both the 94 articles obtained in the first
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Figure 3. The frequency of isolation (%) of E. coli and Klebsiella spp. from inpatients in different studies.
Table 1. The total number of E. coli strains investigated for
antibiotic resistance.
Antibiotics

Outpatients

Inpatients

Ampicillin

6825

409

Cefuroxime

6927

409

Ceftriaxone

8722

751

Ciprofloxacin

9615

1059

Gentamicin

7613

482

Cotrimoxazole

9615

1026

Carbapenem

4103

680

Piperacillin-tazobactam

7438

678

Nitrofurantoin

1122

306

ESBL

4744

265

Total

10,090

6065

search and the 22 articles that complied with the criteria,
problems were noted in sharing the data obtained from
those articles. These problems are listed as follows:
a) Providing data by integrating them in an
inappropriate way made the utilization of these data
during the review impossible. Examples may include
providing the results of isolation rates of gram-negative
bacteria isolated at microbiology laboratories without
classifying them into sample types or providing the results
of common resistance rates belonging to all gram-negative
bacteria isolated from urinary cultures.
b) Incomplete demographic information or lack of
organization based on information within a study also
complicated inferences from the data. Examples may
include presenting the results without classifying by age
groups.
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c) Information about different agents was easily
accessible for the researchers regarding urinary tract
infections, whereas the fact that the shared information
was limited to only one agent was a factor reducing the
importance of the studies. Examples may include several
studies providing isolation rates of all agents but sharing
the result of antibiotic susceptibility for E. coli alone.
d) In allocating the data obtained from a study,
considering some of the data redundant or insignificant
and not sharing them would create problems in future
review of the results of the studies. Examples may include
not providing isolation rates of rare species, such as
Morganella spp. or Serratia spp.
Along with the articles clearly not complying with
the acceptance criteria, we had to eliminate some articles
among the 94 articles even if they involved a large
number of strains due to the reasons described above
(particularly those listed as points a and b). Some of the
above-mentioned shortcomings were also noted in the
22 articles that complied with the acceptance criteria and
were involved in the review. In assessing the isolation rates,
data regarding E. coli and Klebsiella spp. were accessible,
whereas there were limited data about the other genera
or species. With respect to antibiotic resistance, only
data regarding E. coli were taken under review. These
shortcomings in the publications are also applicable to this
review. Nevertheless, it is worth sharing data regarding
E. coli, for which the isolation rate was found to be
approximately 70% in outpatients and approximately 50%
in inpatients, among urinary tract infection agents.
Urinary tract infections are one of the most common
infections in both in- and outpatient settings (1,2). They
occur with a wide range of diseases from uncomplicated
cystitis to urosepsis, which may be fatal. Therefore, urinary
tract infections are among the infectious diseases with the
most frequent use of therapeutic antibiotics. Intensive
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Figure 4. Resistance rates (%) observed for E. coli in inpatients.
*ESBL rate was obtained for inpatients from only two articles.
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Figure 5. Resistance rates (%) observed for E. coli in outpatients.

use of antibiotics has created the problem of antibiotic
resistance in this disease group and made the treatment of
uncomplicated cases difficult as well.
In Turkey, the most commonly preferred antibiotics for
the treatment of urinary tract infection are cotrimoxazole,
ciprofloxacin, and cephalosporins (19,25). However,
studies published from Turkey have shown that we
have reached the end of the road in the use of these
antibiotics. The results obtained from this review show
that resistance to cotrimoxazole for E. coli has reached
50% and that the empirical use of this antibiotic is only
effective half of the time in terms of treatment. Resistance
to ciprofloxacin and ceftriaxone in inpatients was found
to be approximately 48% and 28%, respectively. The fact

that ESBL production is 20% even in outpatients makes
the magnitude of the resistance problem clearer. Similar
results were also obtained in a systematic review study
published in 2013 generated with the results of 101
articles investigating the antibiotic resistance status of E.
coli strains. According to that study, resistance rates of
cotrimoxazole and ciprofloxacin were approximately 50%
and 55% in outpatients and inpatients, respectively. Again
in that study, the resistance rate of ceftriaxone was found
to be 25% in inpatients (26).
Treatment guidelines published in and outside of
Turkey recommend the use of cotrimoxazole among the
antibiotics specified in the paragraph above, for which
there is evidence of resistance problems (27–29). However,
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Table 2. Standardized resistance rates for cotrimoxazole of
outpatient strains are provided as an example. The more it
deviates from a value of 100, the more extreme will be the
resistance rate of the analyzed strain. This table shows that
cotrimoxazole resistance is distributed almost uniformly among
different regions.
Region

Strain (n)

Cotrimoxazole

Western Anatolia

107

90

Middle Eastern Anatolia

285

99

Aegean

663

89

Aegean

619

90

Aegean

164

97

Eastern Marmara

94

97

Mediterranean

251

95

İstanbul

1892

115

Eastern Marmara

341

72

Middle Eastern Anatolia

98

134

Aegean

4534

101

Mediterranean

100

*

Entire Country

110

96

Eastern Marmara

255

77

İstanbul

54

*

Middle Eastern Anatolia

202

92

Middle Eastern Anatolia

321

*

*No data are available regarding this antibiotic.
General resistance rate = (total observed resistances/total
number of strains).
Expected resistance valuei = (general resistance rate × number of
strains in articlei).
Standardized resistance ratei = (observed resistancei/expected
resistancei) × 100.

the guidelines published by the American Infectious
Diseases Association indicate fosfomycin, nitrofurantoin,
and pivmecillinam as the first-choice antibiotics to replace
cotrimoxazole and recommend quinolone antibiotics
as the second option (28). The treatment guidelines
published by the European Urology Association in 2015
listed cotrimoxazole and ciprofloxacin as alternative
treatment options and recommended fosfomycin,
nitrofurantoin, and pivmecillinam as the first choice (30).
In these guidelines, the recommended threshold value for
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the resistance rate is 20% for treatment with cotrimoxazole
in uncomplicated cystitis and 10% for oral ciprofloxacin
in acute uncomplicated pyelonephritis for empirical
treatment. Considering that the resistance rates for each
region detected in our country are much higher than
the specified values in the above-mentioned guidelines,
adherence to guideline-based medical therapy (GBMT)
requires the exclusion of cotrimoxazole from the treatment
algorithm for urinary tract infections in Turkey.
Based on the results of the present review, nitrofurantoin
was noted as an antibiotic included in those guidelines
and appropriate for empirical treatment, particularly in
outpatient settings, with resistance rates of 5% and 15% for
outpatient and inpatient settings, respectively. Piperacillintazobactam was noted as an antibiotic with a low
resistance rate of 8% in inpatients. There are publications
indicating that piperacillin-tazobactam may be used in the
presence of ESBL-producing E. coli, and there are ongoing
randomized controlled studies comparing its efficacy
against these strains versus carbapenems (31–34). The
European Urology Association guidelines also describe
piperacillin-tazobactam as an alternative antibiotic in
the treatment of acute uncomplicated severe cases (30).
When consideration is given to the frequency of ESBL in
our country, piperacillin-tazobactam appears to be a good
candidate for empirical treatment in an inpatient setting.
Consequently, data on E. coli and Klebsiella spp. were
compiled for isolation frequency, whereas only data
on E. coli were compiled for antibiotic resistance rates.
Nevertheless, it is considered that the results obtained
for E. coli, the most important pathogen among urinary
tract infection agents, will be effective in assisting with
the selection of the right antibiotic to ensure treatment
success.
In conclusion, the application of GBMT requires
awareness of resistance rates against antimicrobial agents
for a successful therapeutic outcome. This systematic
review demonstrated that resistance profiles of commonly
used antimicrobial agents are much higher than the
thresholds set by the international guidelines. Hence,
treatment algorithms for urinary tract infections should
be designed according to Turkey’s antimicrobial resistance
patterns. The high resistance rates against commonly
used antimicrobial agents like ampicillin, cefuroxime,
ciprofloxacin, and cotrimoxazole must be considered
while recommending/selecting these agents for national
guidelines.
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